Form D · Pharmaceuticals
IB Pharmaceuticals Inc.
Raleigh, NC · CIK 0001666690
Offering snapshot reported Feb 12, 2018 · SEC filing
- Reported sold
- $4.8M Offering amount: $4.8M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 29, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 12, 2018 | Initial | $4,800,000 | No comparison | 1 | SEC filing |
| Feb 12, 2018 | Initial | $32,751,768 | No comparison | 168 | SEC filing |
| Dec 4, 2017 | Initial | $1,450,000 | No comparison | 13 | SEC filing |
| May 11, 2017 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Nov 9, 2016 | Amendment | $2,651,600 | $1,203,062vs Feb 11, 2016 | 19 | SEC filing |
| Feb 11, 2016 | Initial | $1,448,538 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-305380
Source: Form D, filed Feb 12, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sandeep Laumas | Director, Executive |
| Jay Madan | Director, Executive |
| Christopher Prior | Executive |
| Chris Prior | Executive |
| Kendyle Woodard | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
8480 Honeycutt Road Suite 120
Raleigh, NC, 27615
Raleigh, NC, 27615